Przejdź do
Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.
Informacje o tej pozycji
Wzór empiryczny (zapis Hilla):
C8H15NO3
Numer CAS:
Masa cząsteczkowa:
173.21
NACRES:
NA.32
PubChem Substance ID:
UNSPSC Code:
12352210
MDL number:
Beilstein/REAXYS Number:
4175740
Nazwa produktu
Swainsonine, synthetic
biological source
synthetic
Quality Level
assay
≥95% (HPLC)
form
solid
solubility
methanol: 5 mg/mL, clear, colorless to light yellow
storage temp.
−20°C
SMILES string
O[C@@H]1CCCN2C[C@@H](O)[C@@H](O)C12
InChI
1S/C8H15NO3/c10-5-2-1-3-9-4-6(11)8(12)7(5)9/h5-8,10-12H,1-4H2/t5-,6-,7?,8-/m1/s1
InChI key
FXUAIOOAOAVCGD-DCDLSZRSSA-N
General description
Swainsonine is produced by endophytes, plant and insect pathogens. It is synthesized from the pipecolic acid and mevalonic acid. Swainsonine is a water-soluble indole alkaloid.
Application
Swainsonine is a potent inhibitor of various α-mannosidases, especially of α-mannosidase II. It inhibits glycoprotein processing and also acts as immune modulator.
Swainsonine has been used:
- to test its effect on neural stem cell proliferation
- to inhibit α-mannosidase in TC-1 tumor cells
- to inhibit β1,6-branching synthesis in hepatocellular carcinoma (HCC) cells
Biochem/physiol Actions
Swainsonine is an inhibitor of α-mannosidase in endoplasmic reticulum and Golgi apparatus. It also activates the natural killer cells. Swainsonine elicits neurologic toxicity and its exposure impairs learning and memory resulting in cognitive deficit. It inhibits hepatocellular carcinoma and sensitizes them to respond to anti-cancer drug paclitaxel.[1]
Ta strona może zawierać tekst przetłumaczony maszynowo.
1 of 1
Ta pozycja | |||
|---|---|---|---|
| assay ≥95% (HPLC) | assay ≥98% (TLC) | assay ≥98% (TLC) | assay ≥98% (TLC) |
| biological source synthetic | biological source - | biological source Metarrhizium anisopliae | biological source - |
| Quality Level 200 | Quality Level 100 | Quality Level 200 | Quality Level 100 |
| form solid | form solid | form lyophilized powder | form solid |
| solubility methanol: 5 mg/mL, clear, colorless to light yellow | solubility water: 1 mg/mL, DMSO: 5 mg/mL, chloroform: soluble | solubility H2O: soluble 1 mg/mL | solubility water: 1 mg/mL |
| storage temp. −20°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C |
Klasa składowania
11 - Combustible Solids
wgk
WGK 3
ppe
dust mask type N95 (US), Eyeshields, Gloves
Wybierz jedną z najnowszych wersji:
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.
Swainsonine biosynthesis genes in diverse symbiotic and pathogenic fungi
Cook D, et al.
G3 (Bethesda, Md.), 7(6), 1791-1797 (2017)
Swainsonine, an alpha-mannosidase inhibitor, may worsen cervical cancer progression through the increase in myeloid derived suppressor cells population
SilveiraCRF, et al.
PLoS ONE, 14(3), e0213184-e0213184 (2019)
N-glycosylation by N-acetylglucosaminyltransferase V enhances the interaction of CD147/basigin with integrin beta1 and promotes HCC metastasis
Cui J, et al.
The Journal of Pathology, 245(1), 41-52 (2018)
Numer pozycji handlu globalnego
| SKU | NUMER GTIN |
|---|---|
| S9263-.1MG | 04061833421697 |
| S9263-.5MG | 04061833421703 |


